SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-21-035291
Filing Date
2021-03-12
Accepted
2021-03-12 08:35:10
Documents
53
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tmb-20201230x10k.htm   iXBRL 10-K 1450630
2 EXHIBIT 4.3 tmb-20201230xex4d3.htm EX-4.3 71785
3 EXHIBIT 23.1 tmb-20201230xex23d1.htm EX-23.1 8680
4 EXHIBIT 31.1 tmb-20201230xex31d1.htm EX-31.1 11073
5 EXHIBIT 31.2 tmb-20201230xex31d2.htm EX-31.2 10258
6 EXHIBIT 32.1 tmb-20201230xex32d1.htm EX-32.1 5044
7 EXHIBIT 32.2 tmb-20201230xex32d2.htm EX-32.2 4996
  Complete submission text file 0001104659-21-035291.txt   5143657

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA tmb-20201230.xsd EX-101.SCH 38559
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20201230_cal.xml EX-101.CAL 31746
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20201230_def.xml EX-101.DEF 155040
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20201230_lab.xml EX-101.LAB 294965
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20201230_pre.xml EX-101.PRE 260808
13 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20201230x10k_htm.xml XML 724722
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38128 | Film No.: 21735528
SIC: 2834 Pharmaceutical Preparations